Oncology Drug Approval - Accelerated

Bridging the gap between biomarkers and In Vitro Companion Diagnostics

Clinical Testing Services

Driving oncology therapies to market while managing risk can be daunting. MolecularMD understands the challenges you face. That's why we provide global clinical trial services - from assay development to trial site support, aimed to not only accelerate your oncology drug development, but also speed up your commercialization.


MolecularMD discusses the clinical application of liquid biopsy or circulating tumor DNA (ctDNA) and its benefits within the field of oncology and companion diagnostics.